|
Jul 18
|
Bayer eyes Nubeqa’s label expansion in prostate cancer following Phase III win
|
|
Jul 18
|
Bayer (BAYRY) Meets Primary Goal in Nubeqa Expanded-Use Study
|
|
Jul 17
|
ORIC Pharmaceuticals (ORIC) Up on Collaboration With Bayer & JNJ
|
|
Jul 17
|
What Could Conquer the Superweeds? Bayer and Others Turn to AI
|
|
Jan 9
|
Regeneron (REGN) Down as Q4 Eylea Preliminary Sales Disappoint
|